Freeline Therapeutics

Last updated: October 10, 2024

Dr Anne Prener, CEO
Dr Anne Prener, CEO
UK | Funding: $302.1M (+)

Website: http://www.freelinetx.com/

Freeline Therapeutics is a biopharmaceutical company specialising in developing liver directed gene therapies for bleeding disorders.